Annual General Meeting of BioGaia
The Annual General Meeting of BioGaia AB (publ) on 6 May 2022 voted, among other things, to approve the following resolutions: · adoption of the income statement and balance sheet and the consolidated income statement and consolidated balance sheet · discharge from liability for the Board members and the CEO · a dividend of SEK 3.63 per share plus an extra dividend of SEK 11.29 per share resulting in a total dividend of SEK 14.92 per share and a grant of SEK 2.9 million to “The Foundation to Prevent Antibiotic Resistance” that was founded by BioGaia in 2017. The purpose of the